In contrast, it has been shown that expression of ANXA1 was related to inhibition of NFκB in pancreatic and colon cancer cell lines [37], while in Adriamycin-resistant bladder cancer, ANXA1 has been reported to be downregulated [38]. Here, NFKB1 is linked to malignant colon neoplasm.